Jasper Therapeutics, Inc.
JSPR
$5.41
$0.030.56%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 20.42M | 18.80M | 17.88M | 17.71M | 17.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 76.24M | 68.68M | 68.15M | 69.99M | 68.86M |
| Operating Income | -76.24M | -68.68M | -68.15M | -69.99M | -68.86M |
| Income Before Tax | -71.27M | -63.53M | -62.44M | -63.93M | -64.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -71.27 | -63.53 | -62.44 | -63.93 | -64.47 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.27M | -63.53M | -62.44M | -63.93M | -64.47M |
| EBIT | -76.24M | -68.68M | -68.15M | -69.99M | -68.86M |
| EBITDA | -74.87M | -67.27M | -67.01M | -68.86M | -67.75M |
| EPS Basic | -4.87 | -4.75 | -5.10 | -5.60 | -6.20 |
| Normalized Basic EPS | -3.04 | -2.97 | -3.21 | -3.55 | -3.86 |
| EPS Diluted | -4.87 | -4.75 | -5.10 | -5.60 | -6.20 |
| Normalized Diluted EPS | -3.04 | -2.97 | -3.21 | -3.55 | -3.86 |
| Average Basic Shares Outstanding | 58.33M | 54.37M | 50.34M | 46.27M | 41.73M |
| Average Diluted Shares Outstanding | 58.33M | 54.37M | 50.34M | 46.27M | 41.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |